Rhythm Pharmaceuticals Inc (RYTM)
52.39
+3.38
(+6.90%)
USD |
NASDAQ |
Nov 04, 13:08
Rhythm Pharmaceuticals Max Drawdown (5Y): 92.10% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 92.10% |
| September 30, 2024 | 92.10% |
| August 31, 2024 | 92.10% |
| July 31, 2024 | 92.10% |
| June 30, 2024 | 92.10% |
| May 31, 2024 | 92.10% |
| April 30, 2024 | 92.10% |
| March 31, 2024 | 92.10% |
| February 29, 2024 | 92.10% |
| January 31, 2024 | 92.10% |
| December 31, 2023 | 92.10% |
| November 30, 2023 | 92.10% |
| October 31, 2023 | 92.10% |
| September 30, 2023 | 92.10% |
| August 31, 2023 | 92.10% |
| July 31, 2023 | 92.10% |
| June 30, 2023 | 92.10% |
| May 31, 2023 | 92.10% |
| April 30, 2023 | 92.10% |
| March 31, 2023 | 92.10% |
| February 28, 2023 | 92.10% |
| January 31, 2023 | 92.10% |
| December 31, 2022 | 92.10% |
| November 30, 2022 | 92.10% |
| October 31, 2022 | 92.10% |
| Date | Value |
|---|---|
| September 30, 2022 | 92.10% |
| August 31, 2022 | 92.10% |
| July 31, 2022 | 92.10% |
| June 30, 2022 | 92.10% |
| May 31, 2022 | 92.10% |
| April 30, 2022 | 84.48% |
| March 31, 2022 | 84.48% |
| February 28, 2022 | 84.48% |
| January 31, 2022 | 82.91% |
| December 31, 2021 | 78.17% |
| November 30, 2021 | 77.59% |
| October 31, 2021 | 72.37% |
| September 30, 2021 | 70.42% |
| August 31, 2021 | 70.42% |
| July 31, 2021 | 63.29% |
| June 30, 2021 | 63.29% |
| May 31, 2021 | 63.29% |
| April 30, 2021 | 63.29% |
| March 31, 2021 | 63.29% |
| February 28, 2021 | 63.29% |
| January 31, 2021 | 63.29% |
| December 31, 2020 | 63.29% |
| November 30, 2020 | 63.29% |
| October 31, 2020 | 63.29% |
| September 30, 2020 | 63.29% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
48.06%
Minimum
Nov 2019
92.10%
Maximum
May 2022
79.05%
Average
88.29%
Median
Max Drawdown (5Y) Benchmarks
| Eli Lilly and Co | 22.48% |
| TG Therapeutics Inc | 93.19% |
| Regeneron Pharmaceuticals Inc | 43.25% |
| Mirum Pharmaceuticals Inc | 63.78% |
| Moderna Inc | 89.10% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -11.88 |
| Beta (5Y) | 2.092 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 142.8% |
| Historical Sharpe Ratio (5Y) | 0.1059 |
| Historical Sortino (5Y) | 0.3487 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.83% |